Tesamorelin × hightidecompounds peptides — lab test, April 2026
COA 2604060081 matches freedomdiagnosticstesting.com's public record. So this test doesn't rest on our review alone — the lab confirms it too.
High2604060081Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 11.59 mg
116% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.9 mg using the measured mass, against 2.5 mg on the label — 16% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 2604060081 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 25 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | freedomdiagnosticstesting.com's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tesamorelin from hightidecompounds peptides, performed by freedomdiagnosticstesting.com on April 7, 2026. Reported purity: 99.016%. Net content: 11.59 mg against 10 mg labeled (116% of label). Tested content exceeds the labeled amount by 16%. Batch TES10-001. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of Tesamorelin from hightidecompounds peptides
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| TES10-004 | 12 Aug 2026 | Kovera Labs | 99.519% | 104% | ✓ Lab-verified |
| TES10-003 | 3 Jul 2026 | Kovera Labs | 99.783% | 113% | ✓ Lab-verified |
| TES10-002 | 26 May 2026 | Kovera Labs | 99.237% | 103% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion